| Literature DB >> 27081304 |
Raziur Rahman1, Saad Haider1, Souparno Ghosh2, Ranadip Pal1.
Abstract
Random forests consisting of an ensemble of regression trees with equal weights are frequently used for design of predictive models. In this article, we consider an extension of the methodology by representing the regression trees in the form of probabilistic trees and analyzing the nature of heteroscedasticity. The probabilistic tree representation allows for analytical computation of confidence intervals (CIs), and the tree weight optimization is expected to provide stricter CIs with comparable performance in mean error. We approached the ensemble of probabilistic trees' prediction from the perspectives of a mixture distribution and as a weighted sum of correlated random variables. We applied our methodology to the drug sensitivity prediction problem on synthetic and cancer cell line encyclopedia dataset and illustrated that tree weights can be selected to reduce the average length of the CI without increase in mean error.Entities:
Keywords: drug sensitivity prediction; heteroscedasticity; probabilistic random forests; variance analysis of random forests
Year: 2016 PMID: 27081304 PMCID: PMC4820080 DOI: 10.4137/CIN.S30794
Source DB: PubMed Journal: Cancer Inform ISSN: 1176-9351
Figure 1Example of probabilistic decision tree.
Algorithmic representation of weight selection.
| STEP 1: Cluster Trees Based on Correlations |
| STEP 2: Let the |
| STEP 3: Assign equal weight
|
Figure 2Example of hierarchical clustering.
MAE, NRMSE, and correlation between actual and predicted responses for 100 samples for different number of trees in the forest.
| TREE | MAE | NRMSE | CORRELATION | ||||||
|---|---|---|---|---|---|---|---|---|---|
| RF | wRF | PRF | RF | wRF | PRF | RF | wRF | PRF | |
| 5 | 0.1437 | 0.1431 | 0.1357 | 0.7785 | 0.7759 | 0.7565 | 0.6560 | 0.6600 | 0.6681 |
| 10 | 0.1126 | 0.1129 | 0.1044 | 0.7623 | 0.7645 | 0.7326 | 0.6535 | 0.6507 | 0.6848 |
| 20 | 0.0937 | 0.0943 | 0.0876 | 0.7103 | 0.7127 | 0.6747 | 0.7435 | 0.7402 | 0.7627 |
| 30 | 0.1319 | 0.1318 | 0.1195 | 0.6383 | 0.6371 | 0.6051 | 0.8169 | 0.8188 | 0.8217 |
| 50 | 0.1240 | 0.1239 | 0.1109 | 0.6737 | 0.6738 | 0.6394 | 0.8151 | 0.8169 | 0.8499 |
Note: Minimum leaf size is 3 and 5 features considered for each split.
for different number of trees in the forest.
| TREE | E( | ||
|---|---|---|---|
| RF | wRF | PRF | |
| 5 | 0.5596 | 0.5586 | 0.5617 |
| 10 | 0.6467 | 0.6467 | 0.6655 |
| 20 | 0.7049 | 0.7034 | 0.7226 |
| 30 | 0.6328 | 0.6335 | 0.6281 |
| 50 | 0.6043 | 0.6042 | 0.6303 |
Note: Minimum leaf size is 3 and 5 features considered for each split.
Change in CI width for different CLs between RF and PRF and wRF and PRF model for 100 samples for different number of trees in the forest.
| TREE | % DECREASE IN MEAN CI COMPARED TO RF | % DECREASE IN MEAN CI COMPARED TO wRF | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 50% CL | 70% CL | 80% CL | 95% CL | 99% CL | 50% CL | 70% CL | 80% CL | 95% CL | 99% CL | |
| 5 | 7.52 | 9.29 | 10.13 | 8.99 | 6.31 | 6.49 | 8.06 | 8.57 | 8.20 | 5.79 |
| 10 | 0.14 | 0.63 | 0.78 | 1.55 | 1.98 | 0.72 | 0.81 | 1.00 | 1.55 | 1.92 |
| 20 | 3.16 | 2.43 | 1.93 | 0.73 | 0.50 | 3.16 | 2.34 | 1.78 | 0.64 | 0.34 |
| 30 | 12.78 | 13.45 | 12.53 | 9.65 | 7.54 | 12.92 | 13.36 | 13.01 | 9.65 | 7.56 |
| 50 | 3.94 | 2.61 | 2.55 | 1.41 | 1.65 | 3.79 | 2.43 | 2.48 | 1.32 | 1.74 |
Note: Minimum leaf size is 3 and 5 features considered for each split.
NRMSE, correlation between actual and predicted output, and change in CI width for different CLs for 250 samples for different number of trees in the forest.
| TREE | % DECREASE IN MEAN CI WITH PRF COMPARED TO RF | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRMSE | CORRELATION | DIFFERENT CONFIDENCE LEVEL | |||||||||
| RF | wRF | PRF | RF | wRF | PRF | 50% | 70% | 80% | 95% | 99% | |
| 5 | 0.5880 | 0.5871 | 0.5710 | 0.8177 | 0.8182 | 0.8240 | 4.66 | 4.36 | 4.63 | 4.61 | 4.02 |
| 10 | 0.5503 | 0.5498 | 0.5299 | 0.8396 | 0.8400 | 0.8529 | 4.19 | 4.45 | 3.92 | 3.26 | 2.87 |
| 20 | 0.5746 | 0.5750 | 0.5681 | 0.8243 | 0.8241 | 0.8302 | 3.86 | 3.07 | 2.77 | 2.60 | 2.79 |
| 30 | 0.5830 | 0.5832 | 0.5809 | 0.8180 | 0.8178 | 0.8185 | 1.36 | 1.34 | 1.51 | 1.35 | 1.26 |
| 50 | 0.5821 | 0.5826 | 0.5626 | 0.8259 | 0.8258 | 0.8380 | 4.19 | 3.15 | 2.90 | 2.73 | 2.89 |
Note: Minimum leaf size is 3 and 5 features considered for each split.
Coverage probabilities for four CIs (CL) for PRF and RF predictions for different drugs.
| DRUG | COVERAGE PROBABILITY | |||||||
|---|---|---|---|---|---|---|---|---|
| 50% CL | 70% CL | 80% CL | 95% CL | |||||
| RF | PRF | RF | PRF | RF | PRF | RF | PRF | |
| 17-AAG | 0.686 | 0.650 | 0.911 | 0.883 | 0.977 | 0.959 | 1 | 1 |
| AZD0530 | 0.829 | 0.764 | 0.934 | 0.929 | 0.949 | 0.959 | 0.994 | 0.989 |
| AZD6244 | 0.743 | 0.712 | 0.920 | 0.893 | 0.951 | 0.938 | 0.991 | 0.986 |
| Erlotinib | 0.844 | 0.836 | 0.931 | 0.939 | 0.982 | 0.991 | 0.991 | 1 |
| Lapatinib | 0.838 | 0.788 | 0.932 | 0.898 | 0.974 | 0.949 | 1 | 1 |
| Nilotinib | 0.795 | 0.742 | 0.913 | 0.881 | 0.956 | 0.913 | 0.986 | 0.989 |
| Nutlin-3 | 0.872 | 0.825 | 0.941 | 0.953 | 0.953 | 0.965 | 1 | 1 |
| Paclitaxel | 0.707 | 0.671 | 0.909 | 0.886 | 0.969 | 0.959 | 1 | 0.997 |
| PD-0325901 | 0.686 | 0.665 | 0.893 | 0.872 | 0.965 | 0.944 | 0.996 | 0.996 |
| PD-0332991 | 0.849 | 0.831 | 0.973 | 0.929 | 0.991 | 0.964 | 1 | 0.991 |
| PF2341066 | 0.842 | 0.808 | 0.931 | 0.938 | 0.972 | 0.965 | 0.993 | 1 |
| PHA-665752 | 0.855 | 0.842 | 0.973 | 0.960 | 1 | 1 | 1 | 1 |
| PLX4720 | 0.9 | 0.785 | 0.971 | 0.942 | 0.985 | 0.957 | 0.985 | 0.985 |
| Sorafenib | 0.901 | 0.862 | 0.950 | 0.950 | 0.980 | 0.970 | 0.99 | 0.99 |
| TAE684 | 0.816 | 0.771 | 0.955 | 0.948 | 0.982 | 0.965 | 0.996 | 0.996 |
Note: We have used T = 10 trees and the following constraints for the weights of the trees for PRF model and .
Coverage probabilities for four CIs for different number of trees (from 2 to 100) for drug 17-AAG with 395 samples.
| NO. OF TREES | COVERAGE PROBABILITY | |||||||
|---|---|---|---|---|---|---|---|---|
| 50% CL | 70% CL | 80% CL | 95% CL | |||||
| RF | PRF | RF | PRF | RF | PRF | RF | PRF | |
| T = 2 | 0.6532 | 0.6228 | 0.8228 | 0.8101 | 0.8911 | 0.8886 | 0.9848 | 0.9873 |
| T = 5 | 0.6937 | 0.6658 | 0.9038 | 0.8861 | 0.9570 | 0.9418 | 0.9975 | 0.9949 |
| T = 10 | 0.686 | 0.650 | 0.911 | 0.883 | 0.977 | 0.959 | 1 | 1 |
| T = 20 | 0.7089 | 0.6886 | 0.9139 | 0.9089 | 0.9747 | 0.9722 | 1 | 1 |
| T = 100 | 0.7291 | 0.7241 | 0.9342 | 0.9266 | 0.9823 | 0.9772 | 1 | 1 |
Note: Results for both RF and PRF models show similar type of behavior.
Performance of all the drugs in terms of MSE, MAE, and NRMSE.
| DRUG | MSE | MAE | NRMSE | ||||||
|---|---|---|---|---|---|---|---|---|---|
| RF | wRF | PRF | RF | wRF | PRF | RF | wRF | PRF | |
| 17-AAG | 0.0175 | 0.0167 | 0.0185 | 0.1075 | 0.1051 | 0.1108 | 1.0055 | 0.9828 | 1.0363 |
| AZD0530 | 0.0071 | 0.0066 | 0.0078 | 0.0628 | 0.0605 | 0.0650 | 1.0023 | 0.9637 | 1.0502 |
| AZD6244 | 0.0157 | 0.0160 | 0.0169 | 0.0983 | 0.1018 | 0.1011 | 0.9567 | 0.9642 | 0.9946 |
| Erlotinib | 0.0047 | 0.0049 | 0.0057 | 0.0513 | 0.0528 | 0.0573 | 0.9956 | 1.0021 | 1.0894 |
| Lapatinib | 0.0070 | 0.0073 | 0.0079 | 0.0629 | 0.0616 | 0.0649 | 0.9799 | 0.9992 | 1.0418 |
| Nilotinib | 0.0241 | 0.0226 | 0.0230 | 0.1015 | 0.0931 | 0.0974 | 1.0326 | 1.0021 | 1.0116 |
| Nutlin-3 | 0.0034 | 0.0038 | 0.0037 | 0.0435 | 0.0449 | 0.0438 | 0.9762 | 1.0415 | 1.0296 |
| Paclitaxel | 0.0237 | 0.0236 | 0.0243 | 0.1226 | 0.1240 | 0.1257 | 0.9229 | 0.9205 | 0.9354 |
| PD-0325901 | 0.0259 | 0.0254 | 0.0279 | 0.1312 | 0.1306 | 0.1364 | 0.9534 | 0.9446 | 0.9873 |
| PD-0332991 | 0.0053 | 0.0045 | 0.0058 | 0.0573 | 0.0524 | 0.0609 | 0.9825 | 0.9139 | 1.0379 |
| PF2341066 | 0.0075 | 0.0074 | 0.0060 | 0.0646 | 0.0603 | 0.0564 | 1.0578 | 1.0458 | 0.9519 |
| PHA-665752 | 0.0039 | 0.0039 | 0.0039 | 0.0509 | 0.0497 | 0.0488 | 1.0667 | 1.0700 | 1.0616 |
| PLX4720 | 0.0100 | 0.0107 | 0.0106 | 0.0730 | 0.0775 | 0.0720 | 1.0011 | 1.0270 | 1.0283 |
| Sorafenib | 0.0072 | 0.0069 | 0.0063 | 0.0568 | 0.0533 | 0.0505 | 1.0471 | 1.0309 | 0.9923 |
| TAE684 | 0.0087 | 0.0075 | 0.0089 | 0.0696 | 0.0644 | 0.0707 | 0.9682 | 0.8957 | 0.9759 |
| Average | 0.0114 | 0.0112 | 0.0118 | 0.0769 | 0.0755 | 0.0774 | 0.9966 | 0.9869 | 1.0149 |
Note: We have used T = 10 and the following constraints for the weight of the trees for the PRF model and .
Performance of all the drugs in terms of CI.
| DRUG | % DECREASE IN CI COMPARED TO RF | % DECREASE IN CI COMPARED TO wRF | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 50% CL | 70% CL | 80% CL | 95% CL | 99% CL | 50% CL | 70% CL | 80% CL | 95% CL | 99% CL | |
| 17-AAG | 2.43 | 2.39 | 2.11 | 2.03 | 2.28 | 2.41 | 2.34 | 2.11 | 2.00 | 2.29 |
| AZD0530 | 3.04 | 2.20 | 2.18 | 2.56 | 3.15 | 3.09 | 2.20 | 2.17 | 2.56 | 3.15 |
| AZD6244 | 4.6 | 4.57 | 4.48 | 4.76 | 5.10 | 4.60 | 4.61 | 4.50 | 4.77 | 5.12 |
| Erlotinib | −1.92 | −2.13 | −2.02 | −1.34 | 1.20 | −1.81 | −2.26 | −1.98 | −1.27 | 1.24 |
| Lapatinib | 4.25 | 4.77 | 4.70 | 4.04 | 4.62 | 4.21 | 4.89 | 4.64 | 3.94 | 4.65 |
| Nilotinib | 7.87 | 9.07 | 11.76 | 13.12 | 9.60 | 7.39 | 9.20 | 11.87 | 13.29 | 9.84 |
| Nutlin-3 | 8.76 | 6.76 | 5.80 | 5.66 | 7.73 | 8.94 | 6.87 | 5.92 | 5.81 | 7.76 |
| Paclitaxel | 3.02 | 2.97 | 3.07 | 3.26 | 3.35 | 2.96 | 2.93 | 3.12 | 3.25 | 3.37 |
| PD-0325901 | 1.10 | 1.84 | 2.07 | 2.11 | 2.12 | 1.10 | 1.75 | 2.09 | 2.05 | 2.08 |
| PD-0332991 | 2.23 | 1.22 | 0.36 | 0.74 | 1.52 | 2.24 | 0.93 | 0.35 | 0.64 | 1.46 |
| PF2341066 | 3.69 | 4.63 | 4.26 | 3.45 | 3.75 | 3.56 | 4.55 | 4.21 | 3.43 | 3.69 |
| PHA-665752 | 9.65 | 9.11 | 9.06 | 8.79 | 8.35 | 9.47 | 9.01 | 8.98 | 8.70 | 8.37 |
| PLX4720 | 13.12 | 11.08 | 11.85 | 12.85 | 11.41 | 13.13 | 11.55 | 12.03 | 13.12 | 11.51 |
| Sorafenib | −2.46 | −3.15 | −3.65 | −1.50 | 2.34 | −2.39 | −3.23 | −3.48 | −1.47 | 2.31 |
| TAE684 | 4.08 | 3.90 | 3.64 | 3.59 | 3.62 | 4.17 | 3.91 | 3.65 | 3.52 | 3.63 |
Notes: PRF CI ratio denotes the ratio of samples where PRF CI is lower than RF CI or wRF CI. We have used T = 10 and the following constraints for the weight of the trees for the PRF model and .
Figure 3RF generated PDF is more spread out than PRF generated pdf, which implies that the CI of RF generated pdf is higher than PRF generated pdf.
Percentage decrease in mean CI with PRF as compared with RF and wRF for 15 drugs of CCLE dataset.
| DRUG | % DECREASE IN CI COMPARED TO RF | % DECREASE IN CI COMPARED TO wRF | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 50% CL | 70% CL | 80% CL | 95% CL | 99% CL | 50% CL | 70% CL | 80% CL | 95% CL | 99% CL | |
| 17-AAG | 2.43 | 2.39 | 2.11 | 2.03 | 2.28 | 2.41 | 2.34 | 2.11 | 2.00 | 2.29 |
| AZD0530 | 3.04 | 2.20 | 2.18 | 2.56 | 3.15 | 3.09 | 2.20 | 2.17 | 2.56 | 3.15 |
| AZD6244 | 4.6 | 4.57 | 4.48 | 4.76 | 5.10 | 4.60 | 4.61 | 4.50 | 4.77 | 5.12 |
| Erlotinib | −1.92 | −2.13 | −2.20 | −1.34 | 1.20 | −1.84 | −2.26 | −1.98 | −1.27 | 1.24 |
| Lapatinib | 4.25 | 4.77 | 4.70 | 4.04 | 4.62 | 4.21 | 4.89 | 4.64 | 3.94 | 4.65 |
| Nilotinib | 7.87 | 9.07 | 11.76 | 13.12 | 9.60 | 7.39 | 9.20 | 11.87 | 13.29 | 9.84 |
| Nutlin-3 | 8.76 | 6.76 | 5.80 | 5.66 | 7.73 | 8.94 | 6.87 | 5.92 | 5.81 | 7.76 |
| Paclitaxel | 3.02 | 2.97 | 3.07 | 3.26 | 3.35 | 2.96 | 2.93 | 3.12 | 3.25 | 3.37 |
| PD-0325901 | 1.10 | 1.84 | 2.07 | 2.11 | 2.12 | 1.10 | 1.75 | 2.09 | 2.05 | 2.08 |
| PD-0332991 | 2.23 | 1.22 | 0.36 | 0.74 | 1.52 | 2.24 | 0.93 | 0.35 | 0.64 | 1.46 |
| PF2341066 | 3.69 | 4.63 | 4.26 | 3.45 | 3.75 | 3.56 | 4.55 | 4.21 | 3.43 | 3.69 |
| PHA-665752 | 9.65 | 9.11 | 9.06 | 8.79 | 8.35 | 9.47 | 9.01 | 8.98 | 8.70 | 8.37 |
| PLX4720 | 13.12 | 11.08 | 11.85 | 12.85 | 11.41 | 13.13 | 11.55 | 12.03 | 13.12 | 11.51 |
| Sorafenib | −2.46 | −3.15 | −3.65 | −1.50 | 2.34 | −2.39 | −3.23 | −3.48 | −1.47 | 2.31 |
| TAE684 | 4.08 | 3.90 | 3.64 | 3.59 | 3.62 | 4.17 | 3.91 | 3.65 | 3.52 | 3.63 |
Notes: Number of features used for each split is 10, minimum number of samples in a leaf node = 5, T = 10 and PRF constraints and .
Performance of all the drugs in terms of MSE and MAE for PRF compared to RF and wRF.
| DRUG | MSE | MAE | ||||
|---|---|---|---|---|---|---|
| RF | wRF | PRF | RF | wRF | PRF | |
| 17-AAG | 0.0179 | 0.0186 | 0.0171 | 0.1088 | 0.1138 | 0.1044 |
| AZD0530 | 0.0103 | 0.0102 | 0.0079 | 0.0839 | 0.0739 | 0.0737 |
| AZD6244 | 0.0162 | 0.0128 | 0.0133 | 0.1037 | 0.0920 | 0.0927 |
| Erlotinib | 0.0042 | 0.0043 | 0.0045 | 0.0502 | 0.0524 | 0.0503 |
| Lapatinib | 0.0052 | 0.0052 | 0.0058 | 0.0513 | 0.0512 | 0.0565 |
| Nilotinib | 0.0056 | 0.0069 | 0.0042 | 0.0527 | 0.0520 | 0.0490 |
| Nutlin-3 | 0.0042 | 0.0035 | 0.0030 | 0.0436 | 0.0441 | 0.0450 |
| Paclitaxel | 0.0192 | 0.0219 | 0.0182 | 0.1122 | 0.1180 | 0.1098 |
| PD-0325901 | 0.0244 | 0.0231 | 0.0230 | 0.1313 | 0.1233 | 0.1218 |
| PD-0332991 | 0.0050 | 0.0039 | 0.0046 | 0.0535 | 0.0532 | 0.0501 |
| PF2341066 | 0.0046 | 0.0041 | 0.0068 | 0.0445 | 0.0440 | 0.0536 |
| PHA-665752 | 0.0043 | 0.0046 | 0.0030 | 0.0453 | 0.0458 | 0.0427 |
| PLX4720 | 0.0042 | 0.0030 | 0.0068 | 0.0445 | 0.0413 | 0.0512 |
| Sorafenib | 0.0055 | 0.0034 | 0.0031 | 0.0460 | 0.0439 | 0.0443 |
| TAE684 | 0.0120 | 0.0093 | 0.0089 | 0.0850 | 0.0758 | 0.0764 |
| Average | 0.0095 | 0.0090 | 0.0087 | 0.0704 | 0.0683 | 0.0681 |
Notes: Number of features used for building the model is 50, and the number of trees considered is 40. and .
Performance of all the drugs in terms of bias and variance for PRF compared with RF and wRF.
| DRUG | BIAS | VARIANCE | ||||
|---|---|---|---|---|---|---|
| RF | wRF | PRF | RF | wRF | PRF | |
| 17-AAG | 0.0023 | 0.0087 | 0.0020 | 0.0182 | 0.0187 | 0.0173 |
| AZD0530 | −0.0055 | −0.0150 | −0.0005 | 0.0104 | 0.0101 | 0.0080 |
| AZD6244 | −0.0133 | 0.0190 | 0.0037 | 0.0162 | 0.0126 | 0.0135 |
| Erlotinib | 0.0054 | 0.0110 | −0.0054 | 0.0042 | 0.0042 | 0.0045 |
| Lapatinib | −0.0116 | −0.0080 | −0.0142 | 0.0052 | 0.0052 | 0.0057 |
| Nilotinib | −0.0062 | 0.0002 | 0.0012 | 0.0057 | 0.0070 | 0.0043 |
| Nutlin-3 | −0.0102 | 0.0020 | −0.0057 | 0.0042 | 0.0036 | 0.0031 |
| Paclitaxel | 0.0040 | 0.0192 | 0.0351 | 0.0194 | 0.0217 | 0.0171 |
| PD-0325901 | 0.0086 | 0.0025 | −0.0048 | 0.0246 | 0.0234 | 0.0232 |
| PD-0332991 | 0.0118 | 0.0064 | 0.0083 | 0.0050 | 0.0039 | 0.0047 |
| PF2341066 | 0.0012 | −0.0053 | −0.0003 | 0.0047 | 0.0041 | 0.0069 |
| PHA-665752 | −0.0045 | −0.0108 | 0.0058 | 0.0044 | 0.0046 | 0.0030 |
| PLX4720 | −0.0027 | 0.0030 | −0.0038 | 0.0042 | 0.0030 | 0.0069 |
| Sorafenib | −0.0081 | 0.0005 | −0.0028 | 0.0055 | 0.0034 | 0.0032 |
| TAE684 | −0.0009 | 0.0048 | 0.0030 | 0.0122 | 0.0094 | 0.0090 |
| Average | −0.0020 | 0.0025 | 0.0014 | 0.0096 | 0.0090 | 0.0087 |
Notes: Number of features used for building the model is 50, and the number of trees considered is 40. and .
Performance of all the drugs in terms of % decrease in mean CI with PRF as compared with RF and wRF.
| DRUG | % DECREASE IN CI COMPARED TO RF | % DECREASE IN CI COMPARED TO wRF | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 50% CL | 70% CL | 80% CL | 95% CL | 99% CL | 50% CL | 70% CL | 80% CL | 95% CL | 99% CL | |
| 17-AAG | 2.79 | 2.37 | 2.48 | 2.59 | 2.54 | 2.87 | 2.38 | 2.52 | 2.61 | 2.54 |
| AZD0530 | 3.10 | 2.47 | 2.86 | 2.52 | 3.40 | 3.11 | 2.35 | 2.98 | 2.58 | 3.37 |
| AZD6244 | 1.52 | 1.68 | 1.88 | 0.87 | 0.70 | 1.53 | 1.83 | 1.79 | 0.93 | 0.79 |
| Erlotinib | 3.02 | 2.13 | 1.75 | 1.37 | 1.63 | 3.03 | 2.17 | 1.76 | 1.39 | 1.64 |
| Lapatinib | 1.49 | 1.34 | 1.29 | 1.02 | 1.97 | 1.37 | 1.31 | 1.29 | 0.96 | 1.95 |
| Nilotinib | 1.62 | 0.64 | 0.49 | 2.12 | 4.50 | 1.44 | 0.57 | 0.44 | 2.13 | 4.49 |
| Nutlin-3 | 0.01 | −0.61 | −1.01 | −1.18 | 0.06 | 0.07 | −0.65 | −1.01 | −1.14 | 0.08 |
| Paclitaxel | 3.92 | 2.91 | 2.38 | 1.92 | 2.03 | 3.90 | 2.79 | 2.48 | 1.91 | 2.01 |
| PD-0325901 | −0.09 | −0.07 | −0.03 | −0.49 | −0.40 | 0.00 | −0.01 | −0.06 | −0.43 | −0.41 |
| PD-0332991 | 3.38 | 3.13 | 2.58 | 1.65 | 2.35 | 3.39 | 3.13 | 2.55 | 1.57 | 2.29 |
| PF2341066 | 5.76 | 6.09 | 5.08 | 5.06 | 5.88 | 5.82 | 6.02 | 5.15 | 5.05 | 5.80 |
| PHA-665752 | 1.83 | 0.97 | 0.37 | −0.59 | −0.23 | 1.76 | 0.93 | 0.37 | −0.66 | −0.23 |
| PLX4720 | 0.80 | 0.59 | 0.97 | −0.23 | 0.04 | 0.80 | 0.64 | 0.94 | −0.20 | 0.01 |
| Sorafenib | 3.95 | 4.16 | 3.57 | 2.81 | 4.33 | 3.95 | 4.29 | 3.55 | 2.87 | 4.32 |
| TAE684 | 0.61 | 0.40 | 0.02 | −0.68 | −0.33 | 0.70 | 0.44 | 0.02 | −0.62 | −0.33 |
Notes: Number of features used for building the model is 50, and the number of trees considered is T = 40. and .